動物モデル市場規模、シェア、成長分析：動物タイプ別、技術別、用途別、エンドユーザー別、地域別 - 産業予測 2025～2032年

動物モデルの世界市場規模は2023年に28億米ドルと評価され、予測期間（2025-2032年）のCAGRは8.1%で、2024年の30億3,000万米ドルから2032年には56億4,000万米ドルに成長する見通しです。

動物モデル市場は、がんや心血管疾患などの慢性疾患の調査において、人間の生理学を正確に表現しようとする研究者にとって不可欠です。この市場の成長は、複雑な健康問題の発生率の増加と個別化医療の需要によってもたらされます。トランスジェニックマウスのような遺伝子改変モデルの進歩は、遺伝子機能や疾病メカニズムの詳細な調査を可能にします。さらに、患者由来の動物モデルの台頭は、精密医療への動向を後押ししています。倫理的配慮や代替技術などの課題にもかかわらず、市場は繁栄を続け、医薬品開発と科学的理解に貢献しています。米国の動物モデル市場は、今後の予測期間においても持続的なCAGRを維持すると予想されており、将来の成長ポテンシャルが高いことを示しています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

動物モデル市場規模：動物タイプ別& CAGR（2025-2032）

• 市場概要
• マウス
• ねずみ
• モルモット
• ウサギ
• ハムスター
• その他

動物モデル市場規模：技術別& CAGR（2025-2032）

• 市場概要
• クリスパー
• マイクロインジェクション
• 胚性幹細胞注入

動物モデル市場規模：用途別& CAGR（2025-2032）

• 市場概要
• 研究開発
• 生産
• 品質管理

動物モデル市場規模：エンドユーザー別& CAGR（2025-2032）

• 市場概要
• 調査機関
• 教育機関
• 製薬会社
• 契約調査機関

動物モデル市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Charles River Laboratories（USA）
• The Jackson Laboratory（USA）
• Janvier Labs（France）
• Genoway（France）
• Ozgene（Australia）
• Hera Biolabs（UK）
• Crown Bioscience（USA）
• Inotiv（USA）
• Transgenic（Japan）
• JSR Life Sciences（Japan）
• Biocytogen（China）
• Harbour BioMed（China）
• Cyagen Biosciences（China）
• Horizon Discovery（UK）
• Cellectis（France）
• CRISPR Therapeutics（Switzerland）
• Editas Medicine（USA）
• Intellia Therapeutics（USA）

結論と提言

Global Animal Model Market size was valued at USD 2.8 billion in 2023 and is poised to grow from USD 3.03 billion in 2024 to USD 5.64 billion by 2032, growing at a CAGR of 8.1% during the forecast period (2025-2032).

The animal model market is essential for researchers seeking accurate representations of human physiology to study chronic diseases, including cancer and cardiovascular disorders. Growth in this market is driven by the increasing incidence of complex health issues and the demand for personalized medicine. Advancements in genetically modified models, like transgenic mice, enable detailed investigations into gene functions and disease mechanisms. Additionally, the rise of patient-derived animal models supports the trend toward precision medicine. Despite challenges such as ethical considerations and alternative technologies, the market continues to thrive, contributing to drug development and scientific understanding. The US animal model market is expected to maintain a sustainable CAGR in the upcoming forecast period, indicating strong future growth potential.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Animal Model market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Animal Model Market Segments Analysis

Global Animal Model Market is segmented by Animal Type, Technology, Application, End User and region. Based on Animal Type, the market is segmented into Mice, Rat, Guinea Pigs, Rabbits, Hamsters and Others. Based on Technology, the market is segmented into CRISPR, Microinjection and Embryonic Stem Cell Injection. Based on Application, the market is segmented into Research and Development, Production and Quality Control. Based on End User, the market is segmented into Research Institutes, Educational Institutes, Pharmaceutical Companies and Contract Research Organizations. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Animal Model Market

The Global Animal Model market is significantly driven by innovations in genomics and precision medicine, as there is a rising demand for animal models that can closely mimic individual patient characteristics and responses to therapies. Both researchers and pharmaceutical companies are actively employing these models to explore specific genetic variations and create targeted treatments. A notable example is the emergence of patient-derived xenograft (PDX) models, which involve implanting patient tumor samples into animals for efficacy testing, gaining traction in 2022. This approach enables the assessment of treatment effectiveness tailored to each patient, thereby fueling the need for advanced animal models in the realm of personalized medicine.

Restraints in the Global Animal Model Market

While the animal model market has experienced notable progress, ethical issues and concerns regarding animal welfare continue to act as significant barriers as of 2022. The employment of animals in research invites ethical dilemmas and fosters discussions about their humane treatment. Stricter animal welfare regulations and heightened public scrutiny, especially in regions with rigorous standards, have intensified the examination of animal model usage. These ethical considerations and regulatory frameworks not only hinder market growth but also stimulate efforts to innovate and adopt alternative technologies and methodologies that could potentially replace animal models in research, shaping the future of the industry.

Market Trends of the Global Animal Model Market

In 2023, the Global Animal Model market continues to embrace a significant trend towards humanized and translational models, reflecting a heightened commitment to enhancing the relevance of research to human health. This shift involves the integration of human cells, tissues, and genetic modifications into animal models, enabling more accurate mimicking of human physiology and disease mechanisms. Notably, advancements such as humanized mice with functional human immune systems facilitate deeper exploration of complex conditions like immune-related diseases and the efficacy of novel immunotherapies. This evolving focus underscores the industry's objective to improve predictive outcomes in drug development and disease research, positioning humanized models as pivotal in the quest for translational success.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Animal Model Market Size by Animal Type & CAGR (2025-2032)

• Market Overview
• Mice
• Rat
• Guinea Pigs
• Rabbits
• Hamsters
• Others

Global Animal Model Market Size by Technology & CAGR (2025-2032)

• Market Overview
• CRISPR
• Microinjection
• Embryonic Stem Cell Injection

Global Animal Model Market Size by Application & CAGR (2025-2032)

• Market Overview
• Research and Development
• Production
• Quality Control

Global Animal Model Market Size by End User & CAGR (2025-2032)

• Market Overview
• Research Institutes
• Educational Institutes
• Pharmaceutical Companies
• Contract Research Organizations

Global Animal Model Market Size & CAGR (2025-2032)

• North America (Animal Type, Technology, Application, End User)
  • US
  • Canada
• Europe (Animal Type, Technology, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Animal Type, Technology, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Animal Type, Technology, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Animal Type, Technology, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Charles River Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• The Jackson Laboratory (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Janvier Labs (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genoway (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ozgene (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hera Biolabs (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Crown Bioscience (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inotiv (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Transgenic (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• JSR Life Sciences (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biocytogen (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Harbour BioMed (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cyagen Biosciences (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Horizon Discovery (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cellectis (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CRISPR Therapeutics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Editas Medicine (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intellia Therapeutics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations